Walgreens Boots Alliance Inc Could Rise a Lot According to The Today’s Call Option Activity

 Walgreens Boots Alliance Inc Could Rise a Lot According to The Today's Call Option Activity

In today’s session Walgreens Boots Alliance Inc (WBA) registered an unusually high (205) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the April, 2017 call, expecting serious WBA increase. With 205 contracts traded and 4264 open interest for the Apr, 17 contract, it seems this is a quite bullish bet. The option with symbol: WBA170421C00087500 closed last at: $3.45 or 0% . About 1.93 million shares traded hands. Walgreens Boots Alliance Inc (NASDAQ:WBA) has risen 5.03% since April 25, 2016 and is uptrending. It has underperformed by 0.99% the S&P500.

Analysts await Walgreens Boots Alliance Inc (NASDAQ:WBA) to report earnings on January, 5. They expect $1.11 earnings per share, up 7.77% or $0.08 from last year’s $1.03 per share. WBA’s profit will be $1.21 billion for 19.25 P/E if the $1.11 EPS becomes a reality. After $1.07 actual earnings per share reported by Walgreens Boots Alliance Inc for the previous quarter, Wall Street now forecasts 3.74% EPS growth.

Walgreens Boots Alliance Inc (NASDAQ:WBA) Ratings Coverage

Out of 11 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 9 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 82% are positive. Walgreens Boots Alliance has been the topic of 20 analyst reports since August 24, 2015 according to StockzIntelligence Inc. Deutsche Bank maintained the stock with “Buy” rating in Tuesday, August 30 report. The firm earned “Buy” rating on Monday, August 24 by Zacks. The rating was initiated by Robert W. Baird on Friday, January 22 with “Outperform”. On Monday, October 17 the stock rating was upgraded by Jefferies to “Buy”. S&P Research maintained the stock with “Buy” rating in Thursday, October 29 report. Zacks upgraded Walgreens Boots Alliance Inc (NASDAQ:WBA) rating on Tuesday, September 1. Zacks has “Hold” rating and $98 price target. The stock of Walgreens Boots Alliance Inc (NASDAQ:WBA) earned “Buy” rating by UBS on Thursday, October 6. The stock of Walgreens Boots Alliance Inc (NASDAQ:WBA) has “Outperform” rating given on Monday, July 18 by Credit Suisse. The rating was upgraded by RBC Capital Markets to “Buy” on Wednesday, October 28. The stock of Walgreens Boots Alliance Inc (NASDAQ:WBA) has “Outperform” rating given on Monday, October 31 by Wells Fargo.

According to Zacks Investment Research, “Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.”

Walgreens Boots Alliance, Inc. is a holding company. The company has a market cap of $93.02 billion. The Firm is a pharmacy-led health and wellbeing company. It has a 22.35 P/E ratio. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.

WBA Company Profile

Walgreens Boots Alliance, Inc., incorporated on September 2, 2014, is a holding company. The Firm is a pharmacy-led health and wellbeing company. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The Company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.

More recent Walgreens Boots Alliance Inc (NASDAQ:WBA) news were published by: Forbes.com which released: “Ex-Dividend Reminder: Wynn Resorts, Walgreens Boots Alliance and Starbucks” on November 11, 2016. Also Nasdaq.com published the news titled: “Walgreens Boots Alliance, Inc. (WBA) Ex-Dividend Date Scheduled for November …” on November 14, 2016. Investorplace.com‘s news article titled: “Walgreens Boots Alliance Inc (WBA) Sues Theranos for $140 Million” with publication date: November 09, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment